Nanosonics (ASX:NAN) Margin And EPS Growth Reinforce Bullish Valuation Narratives

Simply Wall St.

Feb 25

AdvertisementNanosonics (ASX:NAN) H1 2026 Earnings Snapshot Nanosonics (ASX:NAN) has reported another set of solid numbers for H1 2026, with revenue of A$105.0 million and basic EPS of A$0.036 setting...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2614081122"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2614081122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2614081122?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/30967672-main-header/1585187581533","is_english":true,"pubTime":"2026-02-25 16:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614081122","market":"sg","top_or_hot":-1,"title":"Nanosonics (ASX:NAN) Margin And EPS Growth Reinforce Bullish Valuation Narratives","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementNanosonics (ASX:NAN) H1 2026 Earnings Snapshot Nanosonics (ASX:NAN) has reported another set of solid numbers for H1 2026, with revenue of A$105.0 million and basic EPS of A$0.036 setting...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/nanosonics-asxnan-margin-and-eps-growth-reinforce-bullish-va\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nanosonics (ASX:NAN) Margin And EPS Growth Reinforce Bullish Valuation Narratives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNanosonics (ASX:NAN) Margin And EPS Growth Reinforce Bullish Valuation Narratives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-25 16:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/nanosonics-asxnan-margin-and-eps-growth-reinforce-bullish-va><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementNanosonics (ASX:NAN) H1 2026 Earnings Snapshot Nanosonics (ASX:NAN) has reported another set of solid numbers for H1 2026, with revenue of A$105.0 million and basic EPS of A$0.036 setting...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/nanosonics-asxnan-margin-and-eps-growth-reinforce-bullish-va\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLSG","symbol_name":"2倍做多BLSH ETF-Leverage Shares","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/nanosonics-asxnan-margin-and-eps-growth-reinforce-bullish-va","article_id":"2614081122","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/30967672-main-header/1585187581533"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-nan/nanosonics-shares/news/nanosonics-asxnan-margin-and-eps-growth-reinforce-bullish-va","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614081122","pubTimestamp":1772007955,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Nanosonics (ASX:NAN) H1 2026 Earnings Snapshot\nNanosonics (ASX:NAN) has reported another set of solid numbers for H1 2026, with revenue of A$105.0 million and basic EPS of A$0.036 setting the tone for its latest update. The company’s revenue has moved from A$90.4 million in H1 2024 to A$93.6 million in H1 2025 and now A$105.0 million, while basic EPS has increased from A$0.022 to A$0.032 and then to A$0.036 over the same periods. These results are supported by trailing 12 month EPS of...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BLSG":"2倍做多BLSH ETF-Leverage Shares","BK7503":"科技股","NAN.AU":"NANOSONICS LTD","BK7126":"医疗保健用品","BLSX":"Tradr 2X Long BLSH Daily ETF","BK4112":"金融交易所和数据"},"translate_title":"Nanosonics(ASX：NAN)利润率和每股收益增长强化了看涨的估值叙事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NAN.AU":1.98,"BLSX":0.6,"BLSG":0.6},"content_text":"AdvertisementNanosonics (ASX:NAN) H1 2026 Earnings Snapshot Nanosonics (ASX:NAN) has reported another set of solid numbers for H1 2026, with revenue of A$105.0 million and basic EPS of A$0.036 setting the tone for its latest update. The company’s revenue has moved from A$90.4 million in H1 2024 to A$93.6 million in H1 2025 and now A$105.0 million, while basic EPS has increased from A$0.022 to A$0.032 and then to A$0.036 over the same periods. These results are supported by trailing 12 month EPS of A$0.0676 on revenue of A$207.3 million and net income of A$20.6 million. With the trailing net profit margin at 9.9% and earnings growth in the data running ahead of revenue growth, investors may focus on how sustainable these margin levels appear from here. See our full analysis for Nanosonics. With the headline figures established, the next step is to see how these earnings line up against the prevailing stories around Nanosonics, highlighting where the numbers support the narrative and where they begin to challenge it. See what the community is saying about Nanosonics ASX:NAN Revenue & Expenses Breakdown as at Feb 2026 24.1% earnings growth backs margin story  Over the last 12 months, Nanosonics earned A$20.6 million on A$207.3 million of revenue, with EPS of A$0.0676 and a net profit margin of 9.9% compared with 9.0% in the prior year. Bulls point to this 24.1% earnings growth and five year average of 22.3% a year as support for their view that margins can keep improving, yet the numbers also set a high bar:\n     Consensus narrative expects revenue to grow about 9.8% a year and margins to reach 13.8% in three years. This would be a step up from the current 9.9% margin. Recent trailing revenue of A$207.3 million already sits above the A$183.97 million level from early 2025, so future growth needs to build on a larger base rather than from a low starting point.    Bulls argue that this combination of earnings growth and margin progress could be the start of a longer run in profitability. They set out how that might play out in their full thesis: 🐂 Nanosonics Bull Case High 49.9x P/E and A$10.89 DCF gap  The stock trades on a trailing P/E of 49.9x compared with peers at 40.6x and the Global Medical Equipment industry at 28.2x, while the provided DCF fair value of A$10.89 sits well above the current share price of A$3.38. Bears highlight this premium multiple as a key risk, arguing that any slowdown in growth could matter more here than for cheaper peers. The data both supports and questions that concern:\n     The 49.9x P/E is clearly higher than the 40.6x peer average, so the valuation is sensitive if earnings growth were to slip from the 24.1% rate seen over the last year. Analysts in the dataset point to upside versus an analyst price target of A$4.31, and the A$10.89 DCF fair value estimate suggests that, on those inputs, the current A$3.38 price sits well below that modeled scenario.    Skeptics focus on that 49.9x P/E. If you want to see exactly how the cautious case lines it up against future earnings assumptions, it is set out here: 🐻 Nanosonics Bear Case TTM EPS of A$0.0676 versus semi-annual run rate  The trailing 12 month EPS of A$0.0676 compares with H1 2025 EPS of A$0.0322 and H2 2025 EPS of A$0.0360, which together total A$0.0682, showing the recent half year results sit close to the latest trailing level. Consensus narrative leans on this earnings base and projects annual earnings growth of about 22% alongside revenue growth of roughly 8.6%. The current figures give you a sense of the runway required:\n     Trailing net income of A$20.6 million would need to move toward the A$36.2 million earnings figure referenced in the consensus pathway, which is a sizeable lift from where the company sits today. With trailing revenue at A$207.3 million versus the A$183.97 million figure from early 2025, the business already has some scale, so investors can compare that current size to the A$263.3 million revenue level assumed in the consensus scenario.    Next Steps To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Nanosonics on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves. If this mix of strong opinions has you on the fence, now is a good time to look through the reward signals yourself and decide how comfortable you are with the current setup. To help you weigh that up, take a look at the 4 key rewards our work has highlighted for this company. Explore Alternatives Despite the progress in revenue, earnings and margins, the current 49.9x P/E and the gap to the A$10.89 DCF fair value make the valuation look demanding. If that kind of premium makes you uneasy, now is a smart moment to check out our 6 high quality undervalued stocks that spotlight companies where current prices look more balanced against their fundamentals.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Nanosonics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}